Venture Capital Report
|
|
- Elfrieda Barrett
- 7 years ago
- Views:
Transcription
1 Venture Capital Report Europe 1Q 2016
2 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer a comprehensive view of the trends currently affecting the venture capital market. Highlights for 1Q 2016 include: European venture capital fundraising amount improved significantly from prior quarter and reached a new high; Venture capital investment into European companies declined from 4Q 2015; The number of mergers and acquisitions (M&As) experienced an increase from the last quarter, while the total M&A raised amount decreased significantly; The number of initial public offerings (IPOs) and total amount raised dropped dramatically form 4Q
3 EUROPEAN VENTURE CAPITAL FUNDRAISING ROCKETS IN 1Q 2016 FUNDRAISING 25 European venture capital funds reached a new high of 2.85 billion during 1Q Compared with 4Q 2015, total capital raised more than doubled, and the number of fund closings climbed 19%. Compared with the same period last year, euros raised improved by 169%, and the number of fund closing increased 14%. Index Ventures VIII LP was the largest fund of this quarter, which raised million, accounting for 18% of the total amount raised in 1Q European VC Fundraising Based on multiple closings ( ) Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 Amount Raised ( B) Number of Funds
4 LARGEST EUROPEAN VC FUNDS RAISED IN 1Q 2016 FUNDRAISING Firm Name Fund Name Amount ( M) Location Offering Status Fund Type Fund Category Closing Type Index Ventures Index Ventures VIII LP Geneva, Switzerland Closed Early-stage venture capital Venture Capital Final Rocket Internet AG Rocket Internet Capital Partners Fund Berlin, Germany Open Late-stage venture capital Venture Capital First Endeavour Vision SA Endeavour Medtech Growth LP Geneva, Switzerland Closed Multi-stage venture capital Venture Capital Final Medicxi Ventures Medicxi Ventures I London, United Kingdom Closed Early-stage venture capital Venture Capital Final Creandum Creandum IV Stockholm, Sweden Closed Early-stage venture capital Venture Capital Final 4
5 INVESTMENT INTO EUROPEAN VENTURE-BACKED COMPANIES DECLINED IN 1Q 2016 FINANCING European companies raised 2.4 billion through 411 deals during 1Q 2016, a 29% decline in the amount raised from the prior quarter as well as a 12% drop in the number of deals. Compared with the same period last year, both investment amount and the number of deals decreased, 17% and 2% respectively. Healthcare was the strongest sector of the quarter in terms of attracting investment Equity Financings into Europe-based, VC-backed Companies ( ) Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 Amount Raised ( B) Number of Deals
6 EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES, BY ROUND CLASS ( ) NUMBER OF DEALS FINANCING Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 Seed First Second Later Restart
7 EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES, BY ROUND CLASS ( ) AMOUNT RAISED ( M) FINANCING 2,500 2,000 1,500 1, Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 Seed First Second Later , ,752 2,179 1,873 1, Restart
8 EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES ( ) MEDIAN EQUITY DEAL SIZE ( M) FINANCING Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 Median Equity Deal Size ( M)
9 EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES, BY INDUSTRY GROUP (1Q 2016) FINANCING Healthcare received the largest allocation of investment during 1Q 2016, raising million through 62 deals. The sector attracted a 31% of the total amount invested and a 15% of all deals completed for the quarter. Business and Financial Services ranked the second highest proportion of investment. The sector garnered million across 116 deals, an increase of 5% in deal number and a less than 1% drop in amount invested from 4Q Consumer Services represented the third, receiving million across 97 deals. The sector s investment figure represents 20% of the total equity financing into European VC-backed companies for 1Q Q'16 Industry Breakdown By Number of Deals 1Q 16 Industry Breakdown By Amount Raised 1% 1% 25% 15% 17% 1% 24% 29% 28% 4% Business and Financial Services Consumer Goods Consumer Services Energy & Utilities Healthcare Industrial Goods & Materials Information Technology Business and Financial Services Consumer Goods Consumer Services Energy & Utilities 1% Healthcare 31% 1% 20% Industrial Goods & Materials Information Technology 9
10 TOP 5 DEALS INTO EUROPEAN VC-BACKED COMPANIES (1Q 2016) FINANCING Co. Name Location Industry Code Industry Segment Industry Group Brief Description Close Date Round Type Raised ( M) Round Investors (* denotes lead) Mission Therapeutics Ltd. Cambridge, United Kingdom Biotechnology Therapeutics Biopharmaceuticals Healthcare Developer of drugs designed to improve the management of lifethreatening diseases, particularly cancer. 2/2/2016 3rd Imperial Innovations Group PLC*, Pfizer Venture Investments, Roche Venture Fund, Sofinnova Partners, SR One Ltd., Woodford Investment Management LLP* Autolus Ltd. London, United Kingdom Biotechnology Therapeutics Biopharmaceuticals Healthcare Provider of biopharmaceutical solutions. 3/3/2016 Second Round Perceptive Bioscience Investments Ltd., Woodford Investment Management LLP Student.com (UK) Ltd. London, United Kingdom Hotels / Gambling Travel and Leisure Consumer Services Provider of an accommodation marketplace for students studying abroad. 10/2/2016 First Round Expa Capital, Horizons Ventures Ltd., Individual Investors, Vy Capital Management Co. Ltd.* Blippar.com Ltd. London, United Kingdom Recreational / Home Software Software Information Technology Provider of a mobile image recognition and augmented reality platform. 2/3/2016 Second Round Khazanah Nasional Berhad* Aprea AB Solna, Stockholm Biotechnology Therapeutics Biopharmaceuticals Healthcare Developer of drugs for the treatment of cancer. 9/3/2016 Later 46 5AM Venture Management LLC*, HealthCap Venture Capital*, Sectoral Asset Management Inc., Versant Venture Management LLC* 10
11 MOST ACTIVE INVESTORS FOR EUROPE-BASED, VC-BACKED COMPANIES (1Q 2016) BY DEALS COMPLETED FINANCING Bpifrance Investment High-Tech German Startups Gruenderfonds Group Berlin GmbH Management GmbH & Co. KGaA Jenson Funding Partners LLP Bayern Kapital GmbH Idinvest Partners HV Holtzbrinck Ventures Adviser GmbH Index Ventures 11
12 EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES BY COUNTRY (1Q 2016) FINANCING Number of Deals in 1Q 2016 by Country (Top 4) 29% 27% United Kingdom France The United Kingdom remained as the most favoured destination for equity financing during 1Q 2016, receiving 974 million across 111 deals. The country took 40% of all equity financing from 1Q Germany ranked second. It reached a total 463 million through 75 deals, representing a 19% share of European financing. A 33% decrease in capital invested and 13% drop of the number of deals from last quarter. France occupied third position raising 354 million, 15% of the total for the quarter. Sweden placed fourth based on raising 99 million during 1Q Amount Raised in 1Q 2016 by Country (Top 4) 5% 18% 22% 4% 23% 21% 40% Germany Netherlands Rest of Europe United Kingdom Germany France 15% 19% Sweden 19% Rest of Europe 12
13 EUROPE 1Q 2016 VENTURE EXIT ACTIVITY LIQUIDITY Exit Opportunities for European VC backed Companies ( ) 50 venture-backed M&As took place in Europe during 1Q 2016, a 28% increase from 4Q The number is 6% lower than that of 1Q However, total amount raised through European VCbacked M&As in 1Q 2016 is only 3.7 billion. A 45% drop from the prior quarter and 16% lower than the same period last year. 5 venture-backed IPOs took place during 1Q 2016, a 64% and 58% decrease from 4Q 2015 and 1Q 2015 respectively. 1Q'16 4Q'15 3Q'15 2Q'15 1Q'15 4Q'14 3Q'14 2Q'14 1Q'14 4Q'13 3Q'13 2Q'13 1Q' Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 IPOs M&As
14 TOP 3 M&As IN EUROPE (1Q 2016) LIQUIDITY Company Name Location Brief Description Industry Code Industry Segment Industry Group Close Date Round Type Amount Paid ( M) Acquirer Acano Ltd. Uxbridge, United Kingdom Provider of collaboration infrastructure and conferencing software. Communications Software Software Information Technology 29/1/2016 Acquisition Cisco Systems TouchType Ltd. London, United Kingdom Provider of predictive text entry software. Communications Software Software Information Technology 2/2/2016 Acquisition Microsoft Corp. CityFibre Infrastructure Holdings Plc Provider of dark fibre networks in London, towns and cities outside London United Kingdom on a shared infrastructure basis. Internet Service Providers Communications and Networking Information Technology 14/1/2016 Acquisition KCOM Group Plc 14
15 EUROPEAN VC-BACKED IPOs ( ) LIQUIDITY Both the number of deals and amount raised via IPO during 1Q 2016 dropped significantly from the prior quarter. 5 venture-backed companies went public during 1Q 2016, 64% decrease from the last quarter. IPOs raised 110 million during 1Q 2016, a decline of 82% from the 608 million raised in 4Q The largest European VC-backed IPO of 1Q 2016 was Shield Therapeutics Ltd. The company raised million for its offering on AIM. 2, , , , Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 Raised ( M) through IPO , Number of IPOs
16 TOP 3 IPOs IN EUROPE (1Q 2016) LIQUIDITY Company Name Location Brief Description Industry Code Industry Segment Industry Group Close Date Raised through IPO ( M) Exchange/ Symbol Shield Therapeutics Ltd. United Kingdom Developer of late-state, secondary care-focused pharmaceuticals. Biotechnology Therapeutics Biopharmaceuticals Healthcare 12/2/ AIM: STX Biotechnology Research & Information Network AG Germany Provider of drugs, bioactive natural compounds, and proprietary enzymes for businesses in the chemical, pharmaceutical, food, and cosmetics industries. Pharmaceuticals Biopharmaceuticals Healthcare 9/2/ FWB: BNN Blue Prism Group PLC United Kingdom Provider of Robotic Process Automation (RPA) software. Business Applications Software Software Information Technology 18/3/ LSE: PRSM 16
17 ABOUT US Dow Jones VentureSource helps venture capitalists, corporate development executives, investment bankers and service provider find deal and partnership opportunities, perform comprehensive due diligence and examine trends in venture capital investment, fund-raising and liquidity. It provides accurate, comprehensive data on venture-backed companies including their investors and executives in every region, industry and stage of development throughout the world. The investment figures included in this release are based on aggregate findings of Dow Jones proprietary research and are contained in VentureSource. This data was collected through survey of professional firms, interviews with company executives, and from secondary sources. These venture capital statistics cover equity investments into early stage, innovative companies and do not include companies receiving funding solely from corporate, individual, and/or government investors. Figures contained throughout the report current at time of editorial but are subject to change without notice. No statement herein is to be construed as a recommendation to buy or sell securities or to provide investment advice. 17
18 ABOUT DOW JONES Dow Jones is a global provider of news and business information, delivering content to consumers and organizations around the world across multiple formats, including print, digital, mobile and live events. Dow Jones has produced unrivaled quality content for more than 130 years and today has one of the world s largest newsgathering operations globally. It produces leading publications and products including the flagship Wall Street Journal, America s largest newspaper by paid circulation; Factiva, Barron s, MarketWatch, Financial News, DJX, Dow Jones Risk & Compliance, Dow Jones Newswires and Dow Jones VentureSource. Dow Jones is a division of News Corp [NASDAQ: NWS, NWSA; ASX: NWS, NWSLV]. MEDIA CONTACT: Sophie Bent +44 (0) sophie.bent@dowjones.com 18
Venture Capital Report
Europe 1Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs
More informationVenture Capital Report
U.S. 2Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer
More informationVenture Capital Report
U.S. 4Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer
More informationLife Sciences Financing Summary Europe December 2014
Europe December 2014 In stark contrast to their summer inactivity, private Biotech European companies (Therapeutics & Diagnostics) raised the highest equity financing amount of the year in September with
More informationBacking the companies of tomorrow. //////////////////////////////////////////// Creandum Nordic Technology Exit Analysis
Backing the companies of tomorrow //////////////////////////////////////////// Creandum Nordic Technology Exit Analysis 1 Creandum exit database Database with 300+ private technology company exits 20+
More informationQ2.15: Cleantech and Renewable Energy Investment Review
Q2.15: Cleantech and Renewable Energy Investment Review 02 Welcome to Taylor Wessing s analysis of clean energy investment activity in Europe in the second quarter of 2015 (Q2.15). Total investment in
More informationBiotech funding surges
www.pwc.com Biotech funding surges Biotechnology investments in the fourth quarter of 2014 reached the highest level recorded since the MoneyTree TM data series was launched in 1995, breaking a record
More informationState of the Life Sciences Mergers and Acquisitions Market
State of the Life Sciences Mergers and Acquisitions Market Brian Miller, Managing Partner and Co-Founder, Linden Partners Rich Fante, RF Consulting LLC, Formerly with AstraZeneca Americas Mark Nicholson,
More informationMedia for Equity: the newest VC concept from Europe. Elena Bocharova for Berliner Börsenkreis 30 June, 2015
Media for Equity: the newest VC concept from Europe Elena Bocharova for Berliner Börsenkreis 30 June, 2015 Outline: get excited How do you finance a company? A brief overview Media for Equity: what do
More informationUS PE/VC Benchmark Commentary Quarter and Year Ending December 31, 2013
US PE/VC Benchmark Commentary Quarter and Year Ending December 31, 2013 In 2013, US private equity and venture capital turned in their best annual performance since 2006 and 1999, respectively. Strong
More informationEuropean private equity investment over 40bn in 2014, exits hit record levels, new EVCA data shows
European private equity investment over 40bn in 2014, exits hit record levels, new EVCA data shows Brussels 12 May 2015 European private equity investment rises 14% to 41.5bn in 2014 Over 5,500 European
More informationChoosing the Ideal Structure for your Business Entity and Venture Capital Investment in 2010
Choosing the Ideal Structure for your Business Entity and Venture Capital Investment in 2010 Columbia University Entrepreneurial Program April 2010 www.morganlewis.com Outline I. Overview II. Choosing
More information{ { Women Wheel. at the. Do Female Executives Drive Start-up Success?
{ { Women Wheel at the Do Female Executives Drive Start-up Success? contents Executive Summary 3 1 1.1 1.2 1.3 1.4 1.5 Methodology 5 VentureSource Database 5 Executive Information 5 Success 5 Industry
More informationEurope s fastest growing highimpact
The Tech Tour Growth 50 Europe s fastest growing highimpact private companies in conjunction with: Contents TT Growth 50 Companies 3-4 Key Figures 5-6 Why the Tech Tour Growth 50 7 Sector & Country Analysis
More informationRaising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements
Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements November 2015 Presented by: Stephen Thau 2 BIOTECH IPOS ARE HOT! The Biggest Biotech
More informationQ1 14 Global IPO update. January March 2014
Q1 14 Global IPO update January March 214 Table of contents Section Content Slides 1 214 January March* highlights 4 7 2 Global IPO activity trends Global analysis Regional analysis Industry analysis Stock
More informationQuébec s Venture Capital Market in 2014. Réseau Capital
Québec s Venture Capital Market in 2014 A REPORT PREPARED FOR Réseau Capital FEBRUARY 2015 2015 by Thomson Reuters (Canada); All Rights Reserved All data used for this report derive from the proprietary
More informationQ1.14: Cleantech and Renewable Energy Investment Review
Q1.14: Cleantech and Renewable Energy Investment Review 02 Welcome to Taylor Wessing s analysis of clean energy investment activity in the first quarter of 2014. The year has started on a positive note,
More informationSprott Focused Global Balanced Class Sprott Corporate Class Inc.
Sprott Focused Global Balanced Class Sprott Corporate Class Inc. ANNUAL MANAGEMENT REPORT OF FUND PERFORMANCE DECEMBER 31 2015 The annual management report of fund performance is an analysis and explanation
More informationPRIVATE EQUITY FUNDS IN NORWAY ACTIVITY REPORT 2014
NORWEGIAN VENTURE CAPITAL & PRIVATE EQUITY ASSOCIATION (NVCA) PRIVATE EQUITY FUNDS IN NORWAY ACTIVITY REPORT 204 (SEED VENTURE BUY OUT) 2 ABOUT THE ACTIVITY REPORT 204 The Activity Report 204 is developed
More informationAn Overview of Private Equity
An Overview of Private Equity September 29, 2014 Private Equity Panel Moderator Les Alexander, Partner, Jefferson Capital Partners Panelists Mark Jones, Partner, River Associates Investments Gretchen Perkins,
More informationACA Member Landscape 2009 Different Than 2008 (And Not)
ACA Member Landscape 2009 Different Than 2008 (And Not) April 16, 2009 Summary of ACA Membership April, 2009 Full Members 146 Provisional Members 16 Accredited Investors in 7,062 States & Provinces 49
More informationHow does a venture capitalist appraise investment opportunities?
1 How does a venture capitalist appraise investment opportunities? Michael Queen - Finance Director, 3i Group plc A presentation to: 23 Pensions Convention 2 June 23 A How presentation does a venture to:
More informationUS PE / VC Benchmark Commentary Quarter Ending September 30, 2015
US PE / VC Benchmark Commentary Quarter Ending September 30, 2015 Overview While US private equity and venture capital struggled during third quarter 2015, they both outperformed the S&P 500, the Russell
More informationMarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample
MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm
More informationwww.pwc.com IPO Watch Europe Survey Q2 2011
www.pwc.com IPO Watch Europe Survey Q2 2011 Table of contents Page European IPO activity by value and volume 3 IPO offering value 4 IPO volume and average offering value 5 by market 6 Top five 7 US and
More informationATEL Growth Capital Fund 8, LLC. Financing Tomorrow s Technologies... Today
ATEL Growth Capital Fund 8, LLC Financing Tomorrow s Technologies... Today RISK FACTORS Investors are encouraged to carefully read the Prospectus for ATEL Growth Capital Fund 8, LLC which has been provided
More informationQuarterly Technology M&A Review
Quarterly Technology M&A Review Q4 01 Technology M&A deal value increased considerably in Q4 01, while deal count dipped to the lowest level since Q4 010. Normalized to remove the impact of Softbank s
More informationVENTURE CAPITAL 101 I. WHAT IS VENTURE CAPITAL?
VENTURE CAPITAL 101 I. WHAT IS VENTURE CAPITAL? Venture capital is money provided by an outside investor to finance a new, growing, or troubled business. The venture capitalist provides the funding knowing
More informationAssessing Fund Performance:
Assessing Fund Performance: Using Benchmarks in Venture Capital Venture Capital Update written by: Bronwyn Dylla Bailey Research Director 650.855.3021 bbailey@svb.com Aaron Gershenberg Managing Partner
More informationWhy Venture Capital Does Not Scale
Frost Bank Tower 41 Congress Ave., Suite 295 Austin, TX 7871 (512)721-12 www.santeventures.com Why Venture Capital Does Not Scale Kevin M. Lalande, Managing Director March 15, 211 ASantéVenturesWhitePaperv1.
More informationTrends in Healthcare Investments and Exits 2014
Trends in Healthcare Investments and Exits 214 WRITTEN BY Jonathan Norris Managing Director Silicon Valley Bank t 65 926 126 jnorris@svb.com HEALTHCARE INVESTMENTS STABILIZE AS IPOS SURGE The story of
More informationThe Venture Capital Rebound How to Generate Outsized Returns 2009-2019
White Paper The Venture Capital Rebound How to Generate Outsized Returns 2009-2019 Roland Reynolds, Principal roland@industryventures.com Ken Wallace, Vice President ken@industryventures.com September
More informationIntroduction to VC and MAVCAP August 2013
Introduction to VC and MAVCAP August 2013 www.mavcap.com 1 AGENDA PART I: Brief Introduction to Venture Capital (VC) i. The Funding Spectrum ii. What is VC iii. How VC Works PART II: Brief Introduction
More informationAlain Schmitt Directorate General for Enterprise October 14 th, 2014
Alain Schmitt Directorate General for Enterprise October 14 th, 2014 I. Facts and figures about innovation in France II. Startup financing III. Entrepreneurship culture and ecosystems Worldwide ranking
More informationPrivate Tender Offer Best Practices
Private Tender Offer Best Practices How to Deliver Controlled Liquidity as a Private Company SecondMarket, Inc. 636 Avenue of the Americas New York, NY 10009 212-825-1619 sales@secondmarket.com Introduction:
More informationOverview. carried interest. Copyright 2014 by Cambridge Associates LLC. All rights reserved.
Overview Cambridge Associates LLC Global ex U.S. Developed and Emerging Markets Private Equity and Venture Capital Benchmark Commentary Quarter Ending September 30, 2013 During the third quarter, in U.S.
More informationTHE ENTREPRENEURS REPORT Private Company Financing Trends
THE ENTREPRENEURS REPORT Private Company Financing Trends From the WSGR Database: Financing Trends for Q2 2015 and Rounds by Year - Equity Financings As we reported in Q1 2015, venture money is continuing
More informationForeign Direct Investment
Germany Reports Record High of New Investment Projects Germany is a very attractive location for foreign investors. Germany Trade & Invest (GTAI) and the economic development agencies of the German Federal
More informationNEWS CORPORATION REPORTS THIRD QUARTER RESULTS FOR FISCAL 2016
NEWS CORPORATION REPORTS THIRD QUARTER RESULTS FOR FISCAL 2016 FISCAL 2016 THIRD QUARTER KEY FINANCIAL HIGHLIGHTS Revenues of $1.9 billion compared to $2.0 billion in the prior year Total Segment EBITDA
More informationwww.pwc.com IPO Watch Europe Survey Q1 2011
www.pwc.com IPO Watch Europe Survey Q1 2011 Table of contents Page European IPO activity by value and volume 3 IPO offering value 4 IPO volume 5 IPOs by market 6 Top five IPOs 7 US and Russia 8 Offering
More informationKey contacts. EMEA Investor Intentions Survey 2015. www.cbre.eu. CBRE Research
Key contacts For more information about this regional special report, please contact: Michael Haddock Senior Director, EMEA Research t: +44 7 182 3274 e: michael.haddock@cbre.com For more information regarding
More informationEMEA Investor Intentions Survey 2015
EMEA Investor Intentions Survey 1 CBRE Research B INVESTOR INTENTIONS SURVEY 1 EMEA INVESTOR INTENTIONS SURVEY 1 EMEA 1 Executive summary Real Estate investors intentions in 1 Western Europe is the region
More informationNordic Venture Capital:
Menon Publication Nordic Venture Capital: Cross Border Investments MENON-PUBLICATION NO. 20 /2010 Gjermund Grimsby, Leo A. Grünfeld and Anne Espelien www.menon.no PO. Box 5250 Majorstuen N0303 Oslo Tel:
More informationVenture Capital Returns to Smaller Size Funds
Dialing Down: Venture Capital Returns to Smaller Size Funds Venture Capital Update Written by: Sven Weber Managing Director 650.855.3049 sweber@svb.com Jason Liou Research Senior Associate 650.855.3043
More informationThe Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry
Talentmark Consulting Product Driven People Solutions Press Release The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry Cambridge
More informationTECH TRENDS & INSIGHTS
TECH TRENDS & INSIGHTS Analysis of the Tech Sector in New York Q4 214 ANALYSIS MARCH 215 Highlights P.1 NY VC funding up 53% in 214 P.1 NY takes 15% of Internet VC funding nationally P.3 Late stage deal
More informationBiotech Opportunities for Start-Up Firms in Japan and Asia
Biotech Opportunities for Start-Up Firms in Japan and Asia - Corporate VC s Perspective - Yoshitaka Yoneyama, Ph.D. President & CEO Astellas Venture Management LLC. April 25, 2006 About Astellas Pharma
More informationA guide to London Stock Exchange trading services for equity securities
A guide to London Stock Exchange trading services for equity securities Contents Background 01 Trading services for equity securities 03 SETS 04 SETSqx 06 SEAQ 08 Criteria and process for allocating securities
More informationInvesting in Rapid Growth, High Potential Companies
Growth Capital: Investing in Rapid Growth, High Potential Companies Venture Capital Update written by: John Dominguez Partner 650.855.3048 jdominguez@svbcapital.com Bronwyn Dylla Bailey Research Director
More informationMedical Equipment Monthly Deals Analysis: January 2015- M&A and Investment Trends
Medical Equipment Monthly Deals Analysis: January 2015- M&A and Investment Trends Reference Code: GDME0470MD Publication Date: March 2015 Independent Medical Equipment Research M&A Trends and Analysis
More informationPrivate Markets Trends
CALLAN INVESTMENTS INSTITUTE Private Markets Trends IN THIS ISSUE pg. 1 Private Equity Fundraising Private Equity Market Environment pg. 3 Regulation Trends Private Equity Returns Spring 2014 Private Equity
More informationFIGURES SET NEW EUROPEAN FUNDRAISING AND INVESTMENT RECORDS AND CONFIRM BOOST OF VENTURE CAPITAL
PRESS RELEASE: STRICTLY EMBARGOED FOR RELEASE UNTIL 8AM CET TUESDAY 13 th MARCH 2007 EUROPEAN PRIVATE EQUITY: STRONG 2006 PERFORMANCE DRIVES INCREASED ALLOCATION FIGURES SET NEW EUROPEAN FUNDRAISING AND
More informationwww.pwc.com IPO Watch Europe Survey Q2 2013
www.pwc.com IPO Watch Europe Survey Q2 2013 Contents Quarterly European IPO activity by value and volume 3 Market volatility index and stock market performance 4 IPO offering value 5 IPO volume 6 Top ten
More informationThe German Venture Capital Market from a U.S. Perspective
The German Venture Capital Market from a U.S. Perspective I. Introduction Emerging growth companies in the United States have been benefiting from the sophisticated venture capital market of the United
More informationFact Sheet. Dow Jones Sustainability TM World Enlarged Index ex Alcohol, Tobacco, Gambling, Armaments & Firearms and Adult Entertainment
Dow Jones Sustainability TM World Enlarged Index ex Alcohol, Tobacco, Gambling, Armaments & Firearms and Adult Stated Objective The Dow Jones Sustainability TM World Enlarged Index ex Alcohol, Tobacco,
More informationReport. Q3 2010 US results. PricewaterhouseCoopers National Venture Capital Association. Data provided by Thomson Reuters
PricewaterhouseCoopers National Venture Capital Association Data provided by Thomson Reuters Report Q3 2010 US results The Q3 2010 MoneyTree results are in! This special report provides summary results
More informationVenture Capital Now and After the Dotcom Crash
Research report: July 21 Venture Capital Now and After the Dotcom Crash Yannis Pierrakis Venture Capital Now and After the Dotcom Crash Foreword The future prosperity of the UK depends on the country s
More information2015 Global venture capital confidence survey results How confident are investors? September 15, 2015
2015 Global venture capital confidence survey results How confident are investors? September 15, 2015 Contents Survey methodology, demographics and key findings Economic trends Regional and country investing
More informationRocket Internet Co-Investment Fund
Presentation1 Agenda Page [ P R E S E N T A T I O N T I T L E ] April 2015 Rocket Internet Co-Investment Fund [ C L I E N T N A M E ] 19 th January 2016 1 Disclaimer This document is being presented solely
More informationThe Changing Face of the European Venture Capital Industry: Facts and Analysis
The Changing Face of the European Venture Capital Industry: Facts and Analysis Summary Report on the Survey of European Venture Capital (SEVeCa) Laura Bottazzi (IGIER-Bocconi University and CEPR) http://www.igier.uni-bocconi.it/bottazzi
More informationVenture Capital Secondary Funds The Third Exit Option A smart way to improve fund performance and unlock hidden value
White Paper Venture Capital Secondary Funds The Third Exit Option A smart way to improve fund performance and unlock hidden value Hans Swildens Principal and Founder, Industry Ventures LLC hans@industryventures.com
More informationCanada s Venture Capital Market in Q3 2014. Prepared by Thomson Reuters for Canada s Venture Capital & Private Equity Association
Canada s Venture Capital Market in Q3 2014 Prepared by Thomson Reuters for Canada s Venture Capital & Private Equity Association Table of Contents Canada s VC Market in Q3 2014 3 $ Invested and # Companies
More informationHealthcare IT Funding and M&A
Q2 2015 Healthcare IT Funding and M&A Executive Summary Executive Summary Healthcare IT Funding and M&A 2015 Second Quarter Report Funding and merger & acquisition activity for the Healthcare IT / Digital
More informationStatistics Compendium EBAN 2014. 5.5b
Statistics Compendium EBAN 2014 5.5b The Statistics Compendium is Europe s most extensive annual research on the activity of business angels and business angel networks. It provides information on the
More informationVenture Capital Research Report 4th Quarter 2015
Venture Capital Research Report 4th Quarter 2015 As of 1st January 2016 Contents 1 Venture Capital Market in the United States 1.1 Regional Share of Investment 1.2 Total Amount Invested by Region 1.3 Investment
More informationGlobal Security pipeline Finance and Investment Trends in Homeland Security 2Q 2010
Global Security pipeline Finance and Investment Trends in Homeland Security 2Q 2010 2Q08 3Q08 4Q08 1Q09 2Q09 3Q09 4Q09 $ billion Global Venture Capital & Private Equity Investment 2Q 2010 6.0 5.0 4.0 3.0
More informationOwner managed businesses: Bringing your corporate and personal goals to life
Owner managed businesses: Bringing your corporate and personal goals to life Owner managed businesses PRECISE. PROVEN. PERFORMANCE. Bringing your corporate and personal goals to life Dynamic. Ambitious.
More informationNasdaq Then and Now ECONOMIC RESEARCH. Robert Kavcic, Senior Economist April 24, 2015. Market Performance as of April 24, 2015
Robert Kavcic, Senior Economist April 24, 2015 Nasdaq Then and Now Equity markets rallied this week alongside some better-than-expected technology-sector earnings and a sparse economic calendar. The S&P
More informationKey Steps Before Talking to Venture Capitalists
Key Steps Before Talking to Venture Capitalists Some entrepreneurs may not be familiar with raising institutional capital to grow their businesses. Expansion plans beyond common organic growth are typically
More informationSomerset Capital 3 rd Annual Family Office Survey 2013. Somerset Capital 3 rd Annual Family Office Survey 2013 Page - 1 -
Somerset Capital 3 rd Annual Family Office Survey 2013 Somerset Capital 3 rd Annual Family Office Survey 2013 Page - 1 - SUMMARY In January 2013 Somerset Capital conducted its 3 rd annual survey of the
More informationValuation Practice. ICM Advisors. Intellectual Property & Intangible Assets. Leverage the intangible assets INTELLECTUAL CAPITAL MANAGEMENT
Valuation Practice Intellectual Property & Intangible Assets ICM Advisors INTELLECTUAL CAPITAL MANAGEMENT Leverage the intangible assets Business needs drive IP Valuation Intellectual Property (IP) and
More informationLEAP Capital Israel s Growth Investment Bank www.leapcap.com
$6.15 billion in Israeli tech M&A in 2007 New Israel Office/Fund for Bessemer and DFJ $8,000,000 Equity financing round led by LEAP Capital acted as placement agent and financial advisor to CellGuide.
More informationJanuary 19, 2012 Sony Corporation
January 19, 2012 Sony Corporation Sony Ericsson Reports Fourth Quarter and Full Year 2011 Results and U.S. GAAP Equity Method Results for Sony s Investment in Sony Ericsson Are Expected to Include Valuation
More informationEuropean Tech Venture Coming of Age: Why is PE Getting Interested?
European Tech Venture Coming of Age: Why is PE Getting Interested? Jean-Michel Deligny, Managing Director jmd@silverpeakib.com Thursday 18 th February 016 3 Hanover Square London W1S 1JB United Kingdom
More informationPrivate Equity: Characteristics and Implementation Considerations
FOR INSTITUTIONAL/WHOLESALE OR PROFESSIONAL CLIENT USE ONLY NOT FOR RETAIL DISTRIBUTION Private Equity: Characteristics and Implementation Considerations June 2015 IN BRIEF In an effort to enhance portfolio
More informationPrivate Equity and Venture Capital in Europe
Private Equity and Venture Capital in Europe Markets, Techniques, and Deals Stefano Caselli AMSTERDAM BOSTON HEIDELBERG LONDON NEW YORK OXFORD PARIS SAN DIEGO SAN FRANCISCO SINGAPORE SYDNEY TOKYO ELSEVIER
More informationMoneyTree Report Q3 2014. PricewaterhouseCoopers National Venture Capital Association. Data provided by Thomson Reuters
www.pwcmoneytree.com PricewaterhouseCoopers National Venture Capital Association MoneyTree Report 20 Data provided by Thomson Reuters December 20 The Technology 20 MoneyTree results are in! This special
More informationMerck: Revitalizing Master-Data Management
2013 SAP AG or an SAP affiliate company. All rights reserved. Merck: Revitalizing Master-Data Management Partner Merck KGaA Industry Pharmaceuticals, Chemicals & Life Sciences Products and Services Pharmaceutical
More informationHow Tsinghua Manages its Companies
DO NOT CITE, QUOTE, COPY OR CIRCULATE J Song 1 How Tsinghua Manages its Companies Dr. Jun Song President, Tsinghua Holdings Co. Ltd. Tsinghua University, Beijing 100084, P. R. China Tel: 86-10-62782279,
More informationQuébec s Venture Capital Market in 2010
Québec s Venture Capital Market in 2010 A REPORT PREPARED FOR RÉSEAU CAPITAL Quebec s Private Equity and Venture Capital Association FEBRUARY 2011 2011 by Thomson Reuters (Canada); All Rights Reserved
More informationHalf Year Report 2009
Half Year Report 2009 Oliver Borrmann Andreas van Bon Ralph Günther Dear shareholders and business partners, The second quarter of 2009 failed to bring an upturn in our business of venture capital direct
More informationPharmaceutical sales in Canada have a 2.5 percent share of the global market, making th
Industry Canada (/eic/site/icgc.nsf/eng/home) Home Industries and Business Canadian Life Science Industries Biopharmaceuticals and pharmaceuticals Pharmaceutical industry profile Life Science Industries
More informationFTSE Global Small Cap Index
FTSE FACTSHEET FTSE Global Small Cap Index bmktitle1 The FTSE Global Small Cap Index is derived from FTSE's flagship Global Equity Series universe, which comprises around 7,000 securities worldwide, giving
More informationAbout Our Private Investment Benchmarks
1. What is a benchmark? FREQUENTLY ASKED QUESTIONS A benchmark is a standard of measurement for investment performance. One of the more common types of benchmarks is an index which, in this case, measures
More information2nd FCF IPO Conference
2nd FCF IPO Conference IPOs in the USA and/or Germany Two Perspectives/Two Options Is the Swim Worth It? Weighing Cross-Border Listings April 23, 2015 1 2015 Dechert LLP Introduction Recent trend of U.S.
More informationINDEPENDENT TECHNOLOGY RESEARCH EUROPEAN BILLION DOLLAR COMPANIES 2015. European Unicorns: Do They Have Legs?
INDEPENDENT TECHNOLOGY RESEARCH EUROPEAN BILLION DOLLAR COMPANIES 2015 European Unicorns: Do They Have Legs? Introduction and methodology» In 2014, we were inspired by the post by Aileen Lee of Cowboy
More informationBuying and Selling Stocks
SECTION 3 Buying and Selling Stocks OBJECTIVES KEY TERMS TAKING NOTES In Section 3, you will discuss why people buy stocks describe how stocks are traded explain how the performance of stocks is measured
More informationPennino Corporation TECHNOLOGY TO IMPROVE LIFE
Pennino Corporation TECHNOLOGY TO IMPROVE LIFE Agenda The Opportunity Highlights Corporate Profile NYU Relationship Obesity and Diabetes Graphics and Facts Next Stage of Development Efficacy and Safety
More informationCANADIAN PRIVATE EQUITY BUYOUT REVIEW
CANADIAN PRIVATE EQUITY BUYOUT REVIEW First Half 2015 REUTERS / Mark Blinch Table of Contents Canada s Buyout & PE Market in H1 2015 3 $ Invested and # Companies Financed 5 Top Buyout Deals 9 Canada by
More informationBoston Entrepreneurs Network How to Raise Money
Boston Entrepreneurs Network How to Raise Money Jon Karlen General Partner Flybridge Capital Partners April 1, 2008 Agenda Quick overview of Flybridge State of the VC Industry Recession & Impact on the
More informationFinancing Trends in the Start-up Nation
6th Meeting of the European TTO Circle 20-21 January 2014 Financing Trends in the Start-up Nation Adv. Simon Weintraub ABOUT US Established over 55 years ago 1 of the largest and most dynamic law firms
More informationCapital Market Linkages: How to facilitate cross border trading?
Capital Market Linkages: How to facilitate cross border trading? OIC Member States Stock Exchanges Forum Dr. Jochen Biedermann Istanbul, 02 October 2010 Agenda 1. About Deutsche Börse 2. Capital Market
More informationGLOBAL TRENDS IN CLEAN ENERGY INVESTMENT
09 January 2015 GLOBAL TRENDS IN CLEAN ENERGY INVESTMENT Rebound in clean energy investment in 2014 beats expectations Luke Mills CONTENTS 1. Annual clean energy investment overview 2. Quarterly trends
More informationMarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample
MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm
More informationWE ENGINEER THE FUTURE PRESENTATION OF THE FINANCIAL YEAR 2014
WE ENGINEER THE FUTURE PRESENTATION OF THE FINANCIAL YEAR 2014 ENGINEERING THE FUTURE Together developing the products of tomorrow VISION Our innovation and excellence are your success. Leading provider
More informationDeBondo Capital Limited Presents FRANKFURT STOCK EXCHANGE : LISTING OVERVIEW
DeBondo Capital Limited Presents FRANKFURT STOCK EXCHANGE : LISTING OVERVIEW TABLE OF CONTENTS 2 DEBONDO CAPITAL - INTRODUCTION THE GERMAN STOCK MARKET THE FSE LISTING PROCESS DEBONDO SERVICES DEAL FLOW
More informationEuropean Union trading fees are still +113% higher than similar fees within the US
European Union trading fees are still +113% higher than similar fees within the US Despite large decreases in brokerage commission rates across Europe, all-in trading costs remain high within European
More informationZephyr Monthly M&A Activity Report
The following report details mergers and acquisitions activity in Western Europe in February 2016 using data from the Zephyr database. It focuses on deal activity by target company. Click here to access
More informationQuest for Growth Results for Q3, January-March 2003
Quest for Growth Results for Q3, January-March 2003 1 Jan Keuppens joins Quest Management Investment Manager Quoted Portfolio of Quest for Growth Former technology analyst with AXA Investment Managers,
More information